BALAMINES · Basic Materials · Specialty Chemicals
Composite scorecard: 43/100 — Quality 54 · Valuation 4 · Momentum 83
| Share price | ₹2,275.80 |
| Market cap | ₹7,825 Cr |
| P/E ratio | 46.7 |
| P/B ratio | 4.0 |
| ROE | 9.5% |
| ROCE | 10.1% |
| Dividend yield | 0.46% |
| Book value | ₹610.00 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹1,419 Cr | ₹169 Cr | 19.0% |
| 2025 | ₹1,389 Cr | ₹159 Cr | 17.0% |
| 2024 | ₹1,631 Cr | ₹232 Cr | 20.0% |
| 2023 | ₹2,346 Cr | ₹406 Cr | 26.0% |
| 2022 | ₹2,314 Cr | ₹418 Cr | 27.0% |
Balaji Amines Limited engages in the manufacture and sale of methylamines, ethylamines, and derivatives of specialty chemicals and pharma excipients in India and internationally. The company operates in two segments, Chemicals and Hotel. It offers monomethylamine, dimethylamine, trimethylamine, monoethylamine, diethylamine, triethylamine, and dimethyl and diethyl amino ethanol; and specialty chemicals, including N-methyl pyrrolidone, morpholine, 2-pyrrolidone, N-ethyl-2-pyrrolidone, gamma-butyrolactone, dimethylformamide, acetonitrile, dimethylcarbonate, propylene glycol, and propylene carbona